Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0023
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $397.54 thousand as of November 5, 2025. Its market cap has decreased by -97.68% in one year.
Market Cap
397.54K
Enterprise Value
409.15K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 397.54K, a decrease of -97.55%. That is a compound annual growth rate of -28.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 397.54K | -95.45% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | 3.99M | 18.28% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |